Kinase Inhibitors for Treating Cancer Market Forecast 2014-2024
Dr Dinah Parums. The Role of the Pathologist in Targeted Therapy and Personalized Medicine (NSCLC)
©2004 Millennium Pharmaceuticals, Inc. © 2004 Millennium Pharmaceuticals Inc. Opportunities and Challenges in Utilizing Biomarkers for Drug Development.
LAS - System Biology Lesson
Leptomeningeal mets in solid tumors
The Therapeutic Implications of EML4/ALK, ROS-1 and Other New Biomarkers Lyudmila Bazhenova, MD Associate Clinical Professor Lung Cancer Unit Leader UC.
What Kind of Rash Is It? A Tutorial About a Skin Rash Associated with Epidermal Growth Factor Receptor Inhibitors used in Cancer Treatment Denise Portz.
Predictive Biomarkers of EGFR Targeted Therapy: Beyond KRAS
Management of Skin Toxicities of Anti-EGFR Agents in Patients with Pancreatic Cancer and Other GI Tumors by Using Electronic Communication: Effective and.
Eric Van Cutsem*
Carsten Bokemeyer*
KRAS status and efficacy in the first- line treatment of patients with mCRC treated with FOLFOX with or without cetuximab: The OPUS experience Carsten.
